Necrotising fasciitis
- 1 June 1994
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 343 (8910) , 1427-1428
- https://doi.org/10.1016/s0140-6736(94)92548-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.Journal of Clinical Investigation, 1994
- Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]Journal of Clinical Investigation, 1993
- Superantigens, T Cells, and MicrobesClinical Infectious Diseases, 1992
- Intravenous Immunoglobulin Therapy for Toxic Shock SyndromeJAMA, 1992
- Role of superantigens in the pathogenesis of infectious diseases and their sequelaeCurrent Opinion in Infectious Diseases, 1992
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- The Eagle Effect Revisited: Efficacy of Clindamycin, Erythromycin, and Penicillin in the Treatment of Streptococcal MyositisThe Journal of Infectious Diseases, 1988
- The Postantibiotic EffectAnnals of Internal Medicine, 1987
- Group A streptococci resistant to clindamycin.BMJ, 1970